Free Republic

Bristol-Myers Squibb is buying cancer drugmaker Celgene in a cash and stock deal valued at $74 billion, the companies announced Thursday. Under the agreement, Celgene shareholders will receive one Bristol-Myers Squibb share and $50 in cash for each share held, or $102.43 per share, a premium of 53.7 percent to Celgene's Wednesday close. Shares of Celgene surged 28 percent in midmorning trading, to near $85 per share, while shares of Bristol-Myers Squibb fell 11 percent. "Together with Celgene, we are creating an innovative biopharma leader, with leading franchises and a deep and broad pipeline that will drive sustainable growth and...

Seven mothers united in grief over losing their children to gun violence or excessive use of force by police will put their message in the spotlight tonight when they deliver a speech at the Democratic National Convention in Philadelphia. The group known as the Mothers of the Movement includes Sybrina Fulton, the mother of Trayvon Martin, who was shot while walking in his neighborhood in 2012, and Lezley McSpadden, the mother of Michael Brown, whose death in Ferguson, Missouri, in 2014 at the hands of a police officer set off nationwide protests. Mothers of Trayvon Martin, Eric Garner Offer Emotional...